Back to the Home Page What's New for 23 July 2014

Of Continuing Interest

    CWD Events

  1. Make plans to attend CWD's Focus on Technology: Anaheim 2014 conference, to be held at the Disneyland Hotel in Anaheim, California, from October 24-26, 2014.

New This Week

    Top Stories

  1. We report on Friends for Life 2014.
  2. Athletes inspire kids with diabetes at Friends for Life Conference.
  3. Words of Hope; Part 1 - FFL 2014.
  4. Tell your diabetes team about ISPAD's 40th Anniversary Conference taking place in Toronto, Canada from September 3 – 6, 2014. ISPAD is the only international organization dedicated to the care of children and adolescents with diabetes and this conference is not to be missed! For the scientific program and registration details, visit
  5. Last week's poll asked our readers how much of a financial burden paying for diabetes care and supplies places on their family. This week's poll asks our readers about their reuse of diabetes care products.
  6. The Featured Book of the Week is Cheating Destiny by James S. Hirsch.
  7. This week's Humorous Tidbit is:
    I am home schooling our 5 year old son, who just went on the pump 5 months ago. Today we were learning about the letter 'S'. He was excited. "I know what begins with 'S'- 'Site change'! I'm sure any other teacher would be more than a little perplexed by this answer.
  8. You know you're the parent of a child with diabetes when your child asks you if "water proof" means "toilet proof" in reference to the pump. See more parent humor.
  9. Featured Diabetes Team Question of the Week

  10. The Featured Ask the Diabetes Team Question of the Week is:
    When does the extended dose start working? Is it immediately or one hour after the bolus?
    See the answer.
  11. From the CWD Forums

  12. From the CWD Forums:
    "CGM in the Cloud" - How many are there of us here?
  13. Diabetes Basics

  14. Date Night ... What's That? Finding a babysitter after diabetes.
  15. Diabetes Blogs and Social Media

  16. Opening Up at Friends for Life.
  17. Unexpected Advocacy.
  18. How Often Should I Change My Lancet? (A "Grost").
  19. Facebook users respond to #ShowMeYourPump challenge by Sierra Sandison, Miss Idaho.
  20. Miss Idaho: #ShowMeYourPump!
  21. Why #ShowMeYourPump is not a big deal (but such a big deal).
  22. Show Me Your Pump! An Interview with Miss Idaho.
  23. 3..2..1..GO BIONIC!
  24. CGM in the Cloud: Personal Preferences.
  25. Diabetes and the Bloody Wedding Dress.
  26. I live with an invisible illness.
  27. Guest Post: Becoming a CDE.
  28. The movement has begun.
  29. Have Professional CGMs Passed Their Prime?
  30. Diabetes and depression: seven things to know and resources to help you take action.
  31. Help Define a New Diabetes Anti-Stigma Initiative! (from Co-Founder of the BDI).
  32. Diabetes Videos

  33. Six-Year-Old A Trial Patient For Bionic Pancreas.
  34. Research

  35. Early infant feeding and risk of developing islet autoimmunity and type 1 diabetes.
  36. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
  37. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up. Free full text available in HTML and PDF (via link) formats.
  38. Role of Glucagon-Like Peptide-1 Analogue Versus Amylin as an Adjuvant Therapy in Type 1 Diabetes in a Closed Loop Setting With ePID Algorithm.
  39. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up of the Diabetes Incidence Study in Sweden (DISS). Higher age and BMI at diabetes onset can be important risk factors.
  40. Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes.
  41. Daily Care

  42. Feasibility of Retinal Screening in a Pediatric Population With Type 1 Diabetes Mellitus reports on the success of the retinal screening team at CWD's Friends for Life conferences.
  43. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Free full text available in PDF format.
  44. A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial.
  45. Insulin glargine metabolite 21A -Gly-human insulin (M1) is the principal component circulating in the plasma of young children with type 1 diabetes: results from the PRESCHOOL study.
  46. The outcome of care in people with type 1 diabetes after switching to insulin glargine-based regimens in a real-life setting: a long-term observational study.
  47. The basal insulin dose; a lesson from prolonged fasting in young individuals with type 1 diabetes.
  48. Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus.
  49. Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes.
  50. Prospective Assessment of Hypoglycemia Symptoms in Children and Adults with Type 1 Diabetes.
  51. Investigating Hypoglycaemia in Type 1 diabetes during pregnancy.
  52. Effects of fiber supplementation on glycemic excursions and incidence of hypoglycemia in children with type 1 diabetes. Free full text available in HTML and PDF formats.
  53. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes.
  54. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
  55. Online social networking services in the management of patients with diabetes mellitus: Systematic review and meta-analysis of randomised controlled trials.
  56. Type 1 Diabetes-Associated Cognitive Decline: A Meta-Analysis; an update of the current literature.
  57. Celiac

  58. Looking for coeliac disease in children with type 1 diabetes mellitus.
  59. The changing face and clinical features of celiac disease in children.
  60. Lactobacillus paracasei CBA L74 interferes with gliadin peptides entrance in Caco-2 cells.
  61. Diabetes in the Popular Press

  62. Newly Crowned Miss Idaho Wears Her Insulin Pump With Pride. See also Hey, Miss Idaho, Is That An Insulin Pump On Your Bikini?
  63. 'Bionic Pancreas' Astonishes Diabetes Researchers.
  64. School praised for supporting diabetic pupil.
  65. Mom on a Mission Creates New Glucose Powder.
  66. Press Releases

  67. JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes. See also NewsFlash: Band-Aid Sized Encapsulation Device Goes to FDA!
  68. JDRF appoints Derek Rapp as new President & CEO.

Watch for the   [New!]   indicator throughout the web site. You'll know you found something that's new to these pages. You can also click on it to return to this page.

Receive the What's New page via E-mail
  Receive an e-mail copy of the What's New page each Wednesday evening by visiting the What's New Subscription Page and filling out the registration form. You can also unsubscribe there. It's that easy to stay informed about what's new at the web site and in diabetes.  

Previous Week's What's New Lists.

  Back to the Home Page Return to the Top of This Page

Last Updated: Thursday January 22, 2015 14:27:51
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.